Valink Therapeutics closes $11.8M Pre-A financing round to advance its oncology pipeline, led by redalpine.
Amount Raised
$11.8 Million
Round Type
Pre-Series A
CambridgeBiotechnologyHealth CareTherapeuticsInvestors
Description
Valink Therapeutics Inc. announced the closing of a $11.8 million funding round to expand its oncology pipeline. The funding will enhance the development of bispecific antibody-drug conjugates and is aimed at improving patient outcomes in cancer treatment. The round was led by redalpine with participation from LongeVC and Oxford Science Enterprises
Quick answer
Valink Therapeutics raised $11.8 Million in a Pre-Series A round, dated October 20, 2025. Investors: Oxford Science Enterprises, LongeVC, RV Invest, P53 Invest, Hoxton Ventures and Redalpine. Valink Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did Valink Therapeutics raise?
- Valink Therapeutics raised $11.8 Million in a Pre-Series A round on October 20, 2025.
- Who invested in Valink Therapeutics?
- Oxford Science Enterprises, LongeVC, RV Invest, P53 Invest, Hoxton Ventures and Redalpine are named as investors in this round.
- What does Valink Therapeutics do?
- Valink Therapeutics focusses on synergistic and non-obvious target combinations to create novel multivalent bispecific antibody-drug conjugates (bsADCs) that transform the treatment of solid tumors and other indications.
- Where is Valink Therapeutics based and how big is it?
- Valink Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 26 employees.
- Who are the decision-makers at Valink Therapeutics?
- Fundz holds 1 contact at Valink Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Valink Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Oncotelic Therapeutics raised $275K on December 4, 2025.
- Virax Biolabs raised $5M (Post-IPO Equity) on December 3, 2025.
- Axoltis Pharma raised $21M (Series A) on December 2, 2025.
- Santersus AG raised an undisclosed amount (Series A) on December 1, 2025.
- Azora Therapeutics, Inc. (DE) raised $4.3M on November 28, 2025.
- SymPhysis Medical raised $1.3M (Grant) on November 26, 2025.
Who to call at Valink Therapeutics, and when
A new round usually means Valink Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Valink Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Valink Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Valink Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Valink Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Valink Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.